Insulet Corp
PODD: XNAS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| PF& | LOCK|?&WW | LOCK|<Q$<ZYb |
Insulet Earnings: Solid Quarterly Results Give Way to Impending Deceleration in Second Half
Insulet posted second-quarter constant-currency revenue growth of 23% and an operating margin of 16%, down 330 basis points from the prior-year period, largely due to rising SG&A expense. Management trimmed its 2026 outlook on a softer expected second half, with weakness concentrated in the US.
